Aligos Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $235.4M
Liabilities Breakdown FY2021
Total Liabilities: $50.6M
Asset Breakdown
Total Assets: $235.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $186.8M | 79.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $6.2M | 2.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $42.4M | 18.0% |
Liabilities Breakdown
Total Liabilities: $50.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.0M | 6.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $47.6M | 94.0% |